Alvotech Financial Statements From 2010 to 2025
| ALVO Stock | USD 8.64 0.06 0.70% |
Check Alvotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alvotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Alvotech financial statements analysis is a perfect complement when working with Alvotech Valuation or Volatility modules.
Check out the analysis of Alvotech Correlation against competitors. Alvotech Company Shares Outstanding Analysis
Alvotech's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Alvotech Shares Outstanding | 311.6 M |
Most of Alvotech's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alvotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Alvotech has 311.6 M of shares currently outstending. This is 72.6% higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 45.51% higher than that of the company.
Alvotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Alvotech's current stock value. Our valuation model uses many indicators to compare Alvotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alvotech competition to find correlations between indicators driving Alvotech's intrinsic value. More Info.Alvotech is rated fifth in return on asset category among its peers. It also is rated fifth in profit margin category among its peers fabricating about 3.98 of Profit Margin per Return On Asset. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alvotech's earnings, one of the primary drivers of an investment's value.About Alvotech Financial Statements
Alvotech investors utilize fundamental indicators, such as revenue or net income, to predict how Alvotech Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. The company was founded in 2013 and is headquartered in Reykjavik, Iceland. Alvotech is traded on NASDAQ Exchange in the United States.
Pair Trading with Alvotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alvotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will appreciate offsetting losses from the drop in the long position's value.Moving against Alvotech Stock
| 0.65 | HD | Home Depot | PairCorr |
| 0.59 | TRV | The Travelers Companies | PairCorr |
| 0.57 | GOOG | Alphabet Class C | PairCorr |
| 0.52 | AAPL | Apple Inc Sell-off Trend | PairCorr |
| 0.52 | AXP | American Express | PairCorr |
The ability to find closely correlated positions to Alvotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alvotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alvotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alvotech to buy it.
The correlation of Alvotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alvotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alvotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alvotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Alvotech Correlation against competitors. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.